These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 25312734)

  • 1. Therapies targeting innate immunity for fighting inflammation in atherosclerosis.
    Mendel I; Yacov N; Harats D; Breitbart E
    Curr Pharm Des; 2015; 21(9):1185-95. PubMed ID: 25312734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of anti-atherosclerosis therapy based on the inflammatory and proliferative aspects of the disease.
    Maranhão RC; Leite AC
    Curr Pharm Des; 2015; 21(9):1196-204. PubMed ID: 25312729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
    McLaren JE; Michael DR; Ashlin TG; Ramji DP
    Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2016 Jeffrey M. Hoeg Award Lecture.
    Rouwet E; Lutgens E
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis and immunity: A perspective.
    Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A
    Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel directions in inflammation as a therapeutic target in atherosclerosis.
    Verweij SL; van der Valk FM; Stroes ES
    Curr Opin Lipidol; 2015 Dec; 26(6):580-5. PubMed ID: 26382552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of inflammatory cells and toll-like receptors in atherosclerosis.
    Seneviratne AN; Monaco C
    Curr Vasc Pharmacol; 2015; 13(2):146-60. PubMed ID: 24188491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms.
    Liberale L; Carbone F; Montecucco F; Sahebkar A
    Int J Biochem Cell Biol; 2020 May; 122():105735. PubMed ID: 32126319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
    Kusters PJH; Lutgens E; Seijkens TTP
    Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte fate in atherosclerosis.
    Hilgendorf I; Swirski FK; Robbins CS
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):272-9. PubMed ID: 25538208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoimmunotherapy to treat ischaemic heart disease.
    Duivenvoorden R; Senders ML; van Leent MMT; Pérez-Medina C; Nahrendorf M; Fayad ZA; Mulder WJM
    Nat Rev Cardiol; 2019 Jan; 16(1):21-32. PubMed ID: 30209355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.
    Deroissart J; Porsch F; Koller T; Binder CJ
    Handb Exp Pharmacol; 2022; 270():359-404. PubMed ID: 34251531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
    Martínez GJ; Celermajer DS; Patel S
    Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging anti-inflammatory therapies for atherosclerosis.
    Roubille F; Kritikou EA; Roubille C; Tardif JC
    Curr Pharm Des; 2013; 19(33):5840-9. PubMed ID: 23438958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.